Literature DB >> 17267622

A novel duplication type of CYP2A6 gene in African-American population.

Tatsuki Fukami1, Miki Nakajima, Hiroyuki Yamanaka, Yasunari Fukushima, Howard L McLeod, Tsuyoshi Yokoi.   

Abstract

Human CYP2A6 is responsible for the metabolism of nicotine and its genetic polymorphisms affect smoking behavior and risk of lung cancer. In the present study, we identified a novel type of CYP2A6 gene duplication that is created through an unequal crossover event with the CYP2A7 gene at 5.2 to 5.6 kilobases downstream from the stop codon. The novel duplication type of CYP2A6 was found in African Americans (n = 176) at an allele frequency of 1.7%, but was not found in European-American (n = 187), Korean (n = 209), or Japanese (n = 184) populations. The plasma cotinine/nicotine ratio in subjects possessing the novel CYP2A6 gene duplication with the CYP2A6*1 allele (10.8 +/- 7.0, n = 4) was 1.4-fold higher than that in homozygotes of the wild type (8.0 +/- 5.0, n = 87), although the difference was not statistically significant. The findings in the present study suggested that the novel duplicated CYP2A6 allele, which is specific for African Americans, would increase nicotine metabolism and may affect smoking behavior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267622     DOI: 10.1124/dmd.106.013557

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

1.  CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.

Authors:  Catherine A Wassenaar; Qian Zhou; Rachel F Tyndale
Journal:  Pharmacogenomics       Date:  2015-12-15       Impact factor: 2.533

2.  Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.

Authors:  A Joseph Bloom; Oscar Harari; Maribel Martinez; Pamela A F Madden; Nicholas G Martin; Grant W Montgomery; John P Rice; Sharon E Murphy; Laura J Bierut; Alison Goate
Journal:  Hum Mol Genet       Date:  2012-03-26       Impact factor: 6.150

3.  Ligand-Free Estrogen Receptor α (ESR1) as Master Regulator for the Expression of CYP3A4 and Other Cytochrome P450 Enzymes in the Human Liver.

Authors:  Danxin Wang; Rong Lu; Grzegorz Rempala; Wolfgang Sadee
Journal:  Mol Pharmacol       Date:  2019-08-09       Impact factor: 4.436

Review 4.  PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.

Authors:  Ellen M McDonagh; Catherine Wassenaar; Sean P David; Rachel F Tyndale; Russ B Altman; Michelle Whirl-Carrillo; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-09       Impact factor: 2.089

5.  In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population.

Authors:  Natasa Djordjevic; Juan Antonio Carrillo; Guillermo Gervasini; Slobodan Jankovic; Eleni Aklillu
Journal:  Eur J Clin Pharmacol       Date:  2010-02-13       Impact factor: 2.953

6.  Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.

Authors:  M K Ho; J C Mwenifumbo; N Al Koudsi; K S Okuyemi; J S Ahluwalia; N L Benowitz; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2009-03-11       Impact factor: 6.875

Review 7.  Epidemiology, determinants, and consequences of cigarette smoking in African American women: an integrative review.

Authors:  Lavonda Mickens; Katie Ameringer; Molly Brightman; Adam M Leventhal
Journal:  Addict Behav       Date:  2009-12-21       Impact factor: 3.913

8.  CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people.

Authors:  Matthew J Binnington; Andy Z X Zhu; Caroline C Renner; Anne P Lanier; Dorothy K Hatsukami; Neal L Benowitz; Rachel F Tyndale
Journal:  Pharmacogenet Genomics       Date:  2012-06       Impact factor: 2.089

9.  Co-expression of drug metabolizing cytochrome P450 enzymes and estrogen receptor alpha (ESR1) in human liver: racial differences and the regulatory role of ESR1.

Authors:  Joseph M Collins; Danxin Wang
Journal:  Drug Metab Pers Ther       Date:  2021-04-07

10.  Parasite-host interaction in malaria: genetic clues and copy number variation.

Authors:  Imad Faik; Elisandra Grangeiro de Carvalho; Jürgen Fj Kun
Journal:  Genome Med       Date:  2009-09-02       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.